Stakeholders Advocate for FDA Modernization In Senate Biotech Hearing

 
• By Elizabeth Orr
  
HELP committee chair Sen. Bill Cassidy emphasized the need for reforms including better AI usage and a streamlined reimbursement path for FDA-cleared products. (Shutterstock)

More from Legislation

More from Medtech Insight